BARTOLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 10.621
EU - Europa 5.430
AS - Asia 1.778
SA - Sud America 28
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 9
Totale 17.900
Nazione #
US - Stati Uniti d'America 10.456
IT - Italia 1.736
DE - Germania 879
CN - Cina 664
SE - Svezia 649
IE - Irlanda 642
SG - Singapore 473
RU - Federazione Russa 351
HK - Hong Kong 272
GB - Regno Unito 269
UA - Ucraina 261
CA - Canada 148
FR - Francia 135
FI - Finlandia 119
IN - India 87
VN - Vietnam 84
AT - Austria 72
TR - Turchia 61
ES - Italia 52
ID - Indonesia 45
DK - Danimarca 43
NL - Olanda 40
BE - Belgio 39
PL - Polonia 34
JP - Giappone 28
CZ - Repubblica Ceca 26
CH - Svizzera 22
AU - Australia 18
HU - Ungheria 18
IR - Iran 15
KR - Corea 14
PT - Portogallo 14
BR - Brasile 13
MX - Messico 9
EU - Europa 7
IL - Israele 7
PH - Filippine 7
NO - Norvegia 6
AR - Argentina 5
MD - Moldavia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BD - Bangladesh 4
BG - Bulgaria 4
EC - Ecuador 4
KZ - Kazakistan 4
MY - Malesia 4
A1 - Anonimo 3
DM - Dominica 3
LU - Lussemburgo 3
TN - Tunisia 3
UY - Uruguay 3
ZA - Sudafrica 3
AN - Antille olandesi 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
HR - Croazia 1
IS - Islanda 1
LV - Lettonia 1
NG - Nigeria 1
PK - Pakistan 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 17.900
Città #
Ann Arbor 2.242
Fairfield 949
Woodbridge 895
Chandler 775
Houston 708
Frankfurt am Main 629
Ashburn 564
Dublin 560
Wilmington 540
Milan 412
Seattle 390
Singapore 358
New York 321
Cambridge 316
Dearborn 311
Jacksonville 310
Hong Kong 261
Princeton 244
Menlo Park 188
Nanjing 127
Lawrence 113
Shanghai 108
Altamura 104
Santa Clara 76
Boardman 69
Vienna 69
San Diego 60
Beijing 53
Helsinki 52
Lachine 50
Nanchang 45
Guangzhou 43
Rome 42
Sesto San Giovanni 42
Brussels 37
Toronto 37
Andover 34
Tianjin 34
Lissone 33
Jakarta 32
Fremont 29
Kraków 29
Ottawa 27
Shenyang 27
Chicago 26
Hebei 26
Jinan 26
Dong Ket 24
Los Angeles 24
Tokyo 24
Hangzhou 23
Zhengzhou 23
Dallas 22
London 22
Florence 20
Ningbo 20
Brno 19
Como 19
Norwalk 19
Jiaxing 18
Monza 18
Redmond 18
Changsha 17
Falls Church 17
Munich 17
Bari 14
Mountain View 14
Naples 14
Pune 14
Sacramento 13
Nürnberg 12
Paris 12
Seregno 12
Bologna 11
Bonndorf 11
Latina 11
San Mateo 11
Turin 11
Washington 11
Bergamo 10
Hefei 10
Kunming 10
Leawood 10
Taizhou 10
Brescia 9
Verona 9
Bolzano 8
Buccinasco 8
Cagliari 8
Lodi 8
Piacenza 8
Auburn Hills 7
Cambiago 7
Desio 7
Genoa 7
Lisbon 7
Magenta 7
Phoenix 7
Pisa 7
Tradate 7
Totale 13.129
Nome #
Surveilling COVID-19 emotional contagion on Twitter 473
Disturbi mentali gravi e sindrome metabolica: meta-analisi e studio trasversale comparativo 455
Facial emotion recognition in people with schizophrenia and a history of violence: a mediation analysis 276
Impact of a Mobile E-Health Intervention on Binge Drinking in Young People: The Digital-Alcohol Risk Alertness Notifying Network for Adolescents and Young Adults Project 263
La comorbilità psichiatrica nei soggetti con disturbi correlati all'uso di cannabis 259
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 243
E-health app to reduce binge drinking among adolescents and young adults: the D-ARIANNA Project 236
The mediating role of depression in pathways linking positive and negative symptoms in schizophrenia. A longitudinal analysis using latent variable structural equation modelling 224
Prevalence and Correlates of Binge Drinking among Young Adults Using Alcohol: A Cross-Sectional Survey 220
Adjunctive second-generation antipsychotics for specific symptom domains of schizophrenia resistant to clozapine: A meta-analysis 214
Bipolar disorder, schizophrenia, and metabolic syndrome 208
Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis 208
Cardiovascular risk factors among people with severe mental illness in Italy: A cross sectional comparative study 203
Area-Level Deprivation and Adverse Consequences in People With Substance Use Disorders: Findings From the Psychiatric and Addictive Dual Disorder in Italy (PADDI) Study 202
Ketamine for suicidal ideation treatment: Available evidence remains convincing 200
Purinergic system and suicidal behavior: exploring the link between adenosine A2A receptors and depressive/impulsive features 199
Schizoaffective disorder and metabolic syndrome: A meta-analytic comparison with schizophrenia and other non-affective psychoses 198
Psychotic Disorders and Substance Use Disorders 194
Risk Estimation Modeling and Feasibility Testing for a Mobile eHealth Intervention for Binge Drinking among Young People: The D-ARIANNA (Digital-Alcohol RIsk Alertness Notifying Network for Adolescents and young adults) Project 191
Poverty matters: Cannabis use among people with serious mental illness: Findings from the United States survey on drug use and health, 2015 189
Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis? 188
Cannabidiol for Mood Disorders: A Call for More Research 188
Testing the association of serum uric acid levels with behavioral and clinical characteristics in subjects with major affective disorders: A cross-sectional study 187
Depression after stroke and risk of mortality: A systematic review and meta-analysis 185
Detecting binge drinking and alcohol-related risky behaviours from twitter’s users: An exploratory content-and topology-based analysis 183
Metabolic Syndrome in People Suffering from Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis 182
Cannabis use disorder as a correlate of suicide attempts among people with bipolar disorder 180
Association of depression and SSRIs with mortality after stroke 180
Comorbid Anxiety and Alcohol or Substance Use Disorders: An Overview 179
Disentangling the association between child abuse and eating disorders: A systematic review and meta-analysis 179
Purinergic dysfunction in bipolar disorder: any role for the antioxidant uric acid as a trait and state biomarker? 179
Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis 176
Attempted suicide in people with co-occurring bipolar and substance use disorders: Systematic review and meta-analysis 176
Antipsychotic dose mediates the association between polypharmacy and corrected QT interval 175
The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis 171
Untreated depression and non-medical use of prescription pain relievers: findings from the National Survey on Drug Use and Health 2008-2014 171
Differences in serum uric acid between ‘unipolar’ and ‘bipolar’ depression: Preliminary data 171
Association between depression and non-fatal overdoses among drug users: A systematic review and meta-analysis 169
Metabolic Syndrome Among People with PTSD: Epidemiological Overview 167
Validity and clinical utility of the DSM-5 severity specifier for bulimia nervosa: results from a multisite sample of patients who received evidence-based treatment 167
Testing the role of the antioxidant uric acid as a biomarker of suicidal ideation in subjects with major affective disorders: An exploratory study 164
Therapy and rehabilitation in gambling disorder: Possibilities and limits 162
Ketamine and esketamine for suicidal ideation: Recent progress and practical issues 162
Facial emotion recognition in alcohol and substance use disorders: A meta-analysis 161
Cannabis use disorder and suicide attempts in bipolar disorder: A meta-analysis 160
Web- and text-based interventions for smoking cessation: Meta-analysis and meta-regression 158
Association between depression and neuropathy in people with type 2 diabetes: a meta-analysis 155
Insomnia as an additional clinical correlate of suicidal ideation after stroke 155
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 155
Antioxidant uric acid in treated and untreated subjects with major depressive disorder: A meta-analysis and meta-regression 151
Clinical utility of a single-item test for DSM-5 alcohol use disorder among outpatients with anxiety and depressive disorders 150
Plasma adiponectin levels in schizophrenia and role of second-generation antipsychotics: A meta-analysis 149
Benefits and harms of low and high second-generation antipsychotics doses for bipolar depression: A meta-analysis 149
The association between post-stroke depression and mortality: a metaanalysis 149
Comorbid addiction and major mental illness in Europe: A narrative review 148
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 146
Association between total serum cholesterol and suicide attempts in subjects with major depressive disorder: Exploring the role of clinical and biochemical confounding factors 145
Trends of major depressive episode among people with cannabis use: Findings from the National Survey on Drug Use and Health 2006–2015 145
Pre-discharge predictors of 1-year rehospitalization in adolescents and young adults with severe mental disorders: A retrospective cohort study 143
Posttraumatic stress disorder and risk of obesity: Systematic review and meta-analysis 142
Uric acid levels in subjects with bipolar disorder: A comparative meta-analysis 142
Assessing vulnerability to psychological distress during the COVID-19 pandemic through the analysis of microblogging content 140
Lipid profile and suicide attempt in bipolar disorder: A meta-analysis of published and unpublished data 139
Facial emotion recognition performance influences executive control impairment in Anorexia Nervosa: an exploratory study 138
Engagement in the Overdose RIsk InfOrmatioN (ORION) e-Health Tool for Opioid Overdose Prevention and Self-Efficacy: A Preliminary Study 134
Glial and neuronal markers in bipolar disorder: A meta-analysis testing S100B and NSE peripheral blood levels 134
Acute variations of cytokine levels after antipsychotic treatment in drug-naïve subjects with a first-episode psychosis: A meta-analysis 133
Exploring the association between bipolar disorder and uric acid: A mediation analysis 132
First-generation antipsychotics and QTc: any role for mediating variables? 131
Psychopathology of dual diagnosis: New trumpets and old uncertainties 130
Recent suicide attempts and serum lipid profile in subjects with mental disorders: A cross-sectional study 130
Agreement between DSM-IV and DSM-5 criteria for alcohol use disorder among outpatients suffering from depressive and anxiety disorders 129
From DSM-IV to DSM-5 alcohol use disorder: An overview of epidemiological data 128
Anxious distress in people with major depressive episodes: a cross-sectional analysis of clinical correlates 127
Defense Mechanisms, Personality Disorders and Eating Disorders: a comparison 124
Second-generation antipsychotics and adiponectin levels in schizophrenia: A comparative meta-analysis 123
Purinergic system dysfunctions in subjects with bipolar disorder: a comparative cross-sectional study 119
The multidimensional diagnostic assessment in gambling disorder 118
Risk of hospitalization among patients with co-occurring psychotic and substance use disorders: a 12-year follow-up [Il rischio di ricovero in pazienti comorbili affetti da disturbi psicotici e da uso di sostanze: Follow-up a 12 anni] 117
Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis 117
Prevalence and correlates of QTc prolongation in Italian psychiatric care: Cross-sectional multicentre study 114
Allopurinol as add-on treatment for mania symptoms in bipolar disorder: Systematic review and meta-analysis of randomised controlled trials 114
Severe mental illness and metabolic syndrome: a meta-analysis 112
The antioxidant uric acid and depression: clinical evidence and biological hypotheses 110
Risk and maintenance factors for young women’s DSM-5 eating disorders 109
Professionals’ Digital Training for Child Maltreatment Prevention in the COVID-19 Era: A Pan-European Model 109
Dual Diagnosis in Italy: findings from the Psychiatric and Addictive Dual Diagnosis in Italy (PADDI) Study 108
Purinergic signaling and related biomarkers in depression 108
Famiglie partner del trattamento. advocacy, interventi psicoeducativi e auto-mutuo-aiuto nei disturbi mentali [Families as treatment partners. Advocacy, psychoeducational interventions and mutual self-help] 106
The kynurenine pathway in schizophrenia and other mental disorders: Insight from meta-analyses on the peripheral blood levels of tryptophan and related metabolites 104
Clinical correlates of comorbid attention deficit hyperactivity disorder in adults suffering from bipolar disorder: A meta-analysis 101
The association between PTSD and metabolic syndrome: A role for comorbid depression? 101
Metabolic dysfunctions in people with post-traumatic stress disorder 101
Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophreniaspectrum disorders: Findings from the STAR Network Depot Study 100
Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis 100
Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study 100
Disentangling the Association between ADHD and Alcohol Use Disorder in Individuals Suffering from Bipolar Disorder: A Systematic Review and Meta-Analysis 100
Violence risk and mental disorders (VIORMED-2): A prospective multicenter study in Italy 96
Repurposed drugs as adjunctive treatments for mania and bipolar depression: A meta-review and critical appraisal of meta-analyses of randomized placebo-controlled trials 96
Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study 95
Totale 16.126
Categoria #
all - tutte 65.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.374 0 0 159 227 239 374 354 239 283 210 201 88
2020/20213.023 121 157 328 286 281 314 324 298 247 239 190 238
2021/20222.122 186 185 425 145 132 146 90 106 140 144 161 262
2022/20233.372 373 983 241 295 204 485 86 227 204 60 130 84
2023/20242.557 76 102 119 204 342 573 371 168 210 55 63 274
2024/20251.308 480 634 194 0 0 0 0 0 0 0 0 0
Totale 19.018